Quality Recruiting. Established Experts.

Lead Early Commercial Strategy - Immuno Oncology

Reference Number: 3544
Location: NJ

Our client is a global pharmaceutical company.  They have asked us to assist them in their search for a Lead Early Commercial Strategy – Immuno Oncology

Major tasks and responsibilities will include:

  • Provides insights to global project teams and early project teams on external environment, including competitive landscape, payer/reimbursement requirements, unmet medical needs, and evolving treatment patterns.
  • Understands the drug development process and maintains sufficient R&D fluency to identify commercial implications of early development decisions.
  • Gathers relevant medical expert insights by arranging advisory boards.
  • Develops commercial forecasts; works with other new products colleagues to coordinate and collaborate on development of pipeline assets for patients with same tumor types.
  • Drives commercial considerations of biomarker identification and companion diagnostic development.
  • Establishes key messages for pipeline assets; collaborates with Scientific Communications colleagues to support publication planning.
  • Provides commercial feedback to impact formulation and packaging development decisions.
  • Develops educational tools for external audiences (e.g., compound cards, MOA summaries) and internal constituencies.
  • Champions generic name development and supports clinical trial naming/branding activities.
  • Develops initiatives to support clinical trial enrollment.
  • Serves as lead within early commercial strategy for business development & licensing projects.
  • Coordinates business development & licensing related workload with other early commercial strategy colleagues.
  • Works closely with business development & licensing colleagues and associated team members to develop and refine commercial assessments commensurate with the level of data available.
  • Assess the relevant therapeutic space, standard of care, competitive environment, and evolving treatment paradigm for the external asset.
  • Determines current payer environment and proposes likely pricing strategy.
  • Consults secondary market research and data sources and conducts primary research, as necessary.
  • Conducts due diligence evaluations.
  • Prepares and presents the Company’s commercial capabilities to potential partners.
  • Identifies synergies with in-house pipeline.
  • Engages with teams on option deals to update commercial evaluation when new data is available through triggered option.
  • Advises on optimal commercial deal structure; reviews collaboration contracts.

We seek candidates with the following qualifications:

  • Must have 5 – 8 years of pharmaceutical marketing experience, oncology preferred; with at least 2 years of experience with in-line brand responsibilities.
  • An advanced scientific degree (e.g., PhD, PharmD, MD) is preferred.
  • An MBA is preferred.
  • Requires compound evaluation experience with new products or major line extensions.
  • Must have experience managing complex projects and diverse project teams to achieve goals on time.
  • Requires superior analytical and quantitative skills, and strong communications skills, written, verbal and presentation.
  • Must have understanding of the drug development process, especially regarding opportunities for differentiation and value demonstration.
  • Must have a proven ability to work effectively in a highly matrixed environment.
  • Experience in more than one of the following roles in addition to marketing: strategic planning, business development, diagnostics, or sales is preferred.
  • Must have experience working in a global environment.

If interested, please email your resume as a Word attachment to us, reference 3544.  No calls or faxes, please. Include your daytime phone number and we will contact you confidentially or reply to your email.

Fairway Consulting Group is included in Hunt Scanlon’s list of Top 50 Healthcare & Life Sciences Search Firms.